BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 8243564)

  • 1. Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow.
    Laterveer L; van Damme J; Willemze R; Fibbe WE
    Exp Hematol; 1993 Dec; 21(13):1621-7. PubMed ID: 8243564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice.
    Pruijt JF; Lindley IJ; Heemskerk DP; Willemze R; Fibbe WE
    Stem Cells; 1997; 15(1):50-5. PubMed ID: 9007222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietic effects of interleukin-6 in long-term administration in mice.
    Ishibashi T; Shikama Y; Kimura H; Kawaguchi M; Uchida T; Yamamoto T; Okano A; Akiyama Y; Hirano T; Kishimoto T
    Exp Hematol; 1993 May; 21(5):640-6. PubMed ID: 8513864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.
    Laterveer L; Zijlmans JM; Lindley IJ; Hamilton MS; Willemze R; Fibbe WE
    Exp Hematol; 1996 Oct; 24(12):1387-93. PubMed ID: 8913284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro interaction between interleukin 6 and granulocyte colony-stimulating factor in the regulation of murine hematopoiesis.
    Pojda Z; Tanaka K; Aoki Y; Tsuboi A
    Exp Hematol; 1992 Aug; 20(7):874-8. PubMed ID: 1378408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of murine hematopoiesis in vivo with recombinant murine interleukin-1.
    Gallicchio VS; Shedlofsky SI; Swim AT; Robinson JM; Hulette BC; Messino MJ; Doukas MA
    J Biol Response Mod; 1989 Aug; 8(4):422-39. PubMed ID: 2666587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo administration of interleukin 6 delays hematopoietic regeneration in sublethally irradiated mice.
    Pojda Z; Aoki Y; Sobiczewska E; Machaj E; Tsuboi A
    Exp Hematol; 1992 Aug; 20(7):862-7. PubMed ID: 1628704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 1-induced sequential myelorestoration: dynamic relation between granulopoiesis and progenitor cell recovery in myelosuppressed mice.
    Ido M; Harada M; Furuichi H; Matsuoka N; Nakano K; Sohmura Y
    Exp Hematol; 1992 Feb; 20(2):161-6. PubMed ID: 1371964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic effects of recombinant human interleukin-6 in dogs exposed to a total-body radiation dose of 2.4 Gy.
    Selig C; Kreja L; Müller H; Seifried E; Nothdurft W
    Exp Hematol; 1994 Jul; 22(7):551-8. PubMed ID: 8013570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Megakaryocytopoiesis and granulopoiesis in W/Wv mice: comparisons between bone marrow and spleen.
    Petursson SR; Chervenick PA
    J Lab Clin Med; 1987 Dec; 110(6):773-83. PubMed ID: 3681118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.
    Neelis KJ; Dubbelman YD; Qingliang L; Thomas GR; Eaton DL; Wagemaker G
    Exp Hematol; 1997 Sep; 25(10):1084-93. PubMed ID: 9293906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constant subcutaneous infusion of rhIL-11 in mice: efficient delivery enhances biological activity.
    Leonard JP; Neben TY; Kozitza MK; Quinto CM; Goldman SJ
    Exp Hematol; 1996 Feb; 24(2):270-6. PubMed ID: 8641352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained engraftment of mice transplanted with IL-1-primed blood-derived stem cells.
    Fibbe WE; Hamilton MS; Laterveer LL; Kibbelaar RE; Falkenburg JH; Visser JW; Willemze R
    J Immunol; 1992 Jan; 148(2):417-21. PubMed ID: 1345921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
    Chow FP; Zsebo K; Hamburger AW
    Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of 5-fluorouracil on hematopoiesis: studies of murine megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels.
    Yeager AM; Levin J; Levin FC
    Exp Hematol; 1983 Nov; 11(10):944-52. PubMed ID: 6662215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined interleukin-1 beta/interleukin-6 treatment in mice: synergistic myelostimulatory activity and myelorestorative effect after cyclophosphamide-induced myelosuppression.
    Tritarelli E; Greco G; Testa U; Belardelli F; Peschle C; Proietti E
    Cancer Res; 1994 Dec; 54(24):6469-76. PubMed ID: 7987845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation.
    Inoue H; Koezuka Y; Nishi N; Osawa M; Motoki K; Kobayashi E; Kabaya K; Obuchi M; Fukushima H; Mori KJ
    Exp Hematol; 1997 Aug; 25(9):935-44. PubMed ID: 9257806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
    Gallicchio VS; Hughes NK; Tse KF
    Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential treatment with rmIL-3 or simultaneous treatment with rmIL-3 or rhIL-11 with thrombopoietin (TPO) fails to enhance in vivo neonatal rat thrombocytopoiesis.
    van de Ven C; Fernandez GW; Herbst T; Knoppel A; Cairo MS
    Exp Hematol; 1997 Aug; 25(9):1005-12. PubMed ID: 9257814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.